SCHEMBL20022862

SCHEMBL20022862

CC(N)COCCCOCC(C)OCC(C)N

nearest known ligand 0.44

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL682073 0.96 TDP1 (0.44) TDP1
SCHEMBL6124096 0.91 TDP1 (0.47) TDP1
SCHEMBL12560439 0.89 TDP1 (0.42) TDP1
SCHEMBL10027724 0.89 TDP1 (0.48) TDP1
SCHEMBL12161286 0.88 TDP1 (0.50) TDP1
SCHEMBL17128666 0.87 TDP1 (0.38) TDP1
SCHEMBL321876 0.86 TDP1 (0.40) TDP1
SCHEMBL15070930 0.86 TDP1 (0.44) TDP1
SCHEMBL21835942 0.86 TDP1 (0.48) TDP1
SCHEMBL15819991 0.86 TDP1 (0.48) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180093957-A1 NEW METAL PLATING COMPOSITINOS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093957-A1 NEW METAL PLATING COMPOSITINOS POLR1C, PARG, POLG TDP1 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.